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Abstract
Background: H5N2 avian influenza viruses (AIVs) can infect individuals that are in frequent contact with infected
birds. In 2013, we isolated a novel reassortant highly pathogenic H5N2 AIV strain [A/duck/Zhejiang/6DK19/2013(H5N2)
(6DK19)] from a duck in Eastern China. This study was undertaken to understand the adaptive processes that led
enhanced replication and increased virulence of 6DK19 in mammals. 6DK19 was adapted to mice using serial
lung-to-lung passages (10 passages total). The virulence of the wild-type virus (WT-6DK19) and mouse-adapted
virus (MA-6DK19) was determined in mice. The whole-genome sequences of MA-6DK19 and WT-6DK19 were
compared to determine amino acid differences.
Findings: Amino acid changes were identified in the MA-DK19 PB2 (E627K), PB1 (I181T), HA (A150S), NS1 (seven amino
acid extension “WRNKVAD” at the C-terminal), and NS2 (E69G) proteins. Survival and histology analyses demonstrated
that MA-6DK19 was more virulent in mice than WT-6DK19.
Conclusion: Our results suggest that these substitutions are involved in the enhanced replication efficiency and
virulence of H5N2 AIVs in mammals. Continuing surveillance for H5N2 viruses in poultry that are carrying these
mutations is required.
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Findings
Highly pathogenic H5 avian influenza viruses (AIVs)
emerged from Asia in 2003 and have caused severe
epidemics among poultry and humans [1–4]. Of the
850 human cases reported to the World Health
Organization as of April 4, 2016, 449 (52.8 %) were
fatal [5]. Given that highly pathogenic H5 AIVs con-
tinue to cross into the human population and that
humans lack pre-existing immunity to the viruses,
there is the possibility that a pandemic human influ-
enza virus will emerge.
Live poultry markets (LPMs), sites for the sale and
slaughter of domestic poultry in East Asia [6, 7], are
major venues for AIV dissemination, influenza virus
reassortment, and cross-species transfer of AIVs [6, 8–10].
H5N2 AIVs are consistently found in poultry from
LPMs [4, 11, 12] and transmission to individuals in
frequent contact with infected birds has been well
documented [13, 14]. In addition to active surveil-
lance of LPMs for emergent AIVs, it is necessary to
understand the adaptive processes that cause H5N2
AIVs to become highly pathogenic (defined as
enhanced replication and increased virulence) in
mammals.
Our laboratory has previously isolated a novel reassor-
tant highly pathogenic H5N2 AIV [A/duck/Zhejiang/
6DK19/2013 (H5N2) (6DK19)] from an apparently
healthy domestic duck from a LPM [11]. This study was
undertaken to investigate the amino acid substitutions
associated with adaptation of 6DK19 to mammals, and
to determine the virulence of mouse-adapted 6DK19
in vivo.
All of the animal experiments described in this study
were approved by the Ethics Committee of the First
Affiliated Hospital, School of Medicine, Zhejiang University
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(No. 2015-15). 6DK19 was adapted to a murine host by
serial lung-to-lung passage (10 passages) of the wildtype
(WT) 6DK19 virus as described previously [15, 16] to ob-
tain the mouse-adapted virus [A/duck/Zhejiang/6DK19-
mouse-adapted/2013(H5N2), MA-6DK19]. Six-week-old
female BALB/c mice (n = 5) were inoculated intranasally
with 106.0 EID50 (50 % embryo infectious dose) of 6DK19
in 50 μL of phosphate buffered saline (PBS). Based on pre-
viously published studies, 6DK19 was moderately patho-
genic in mice [11]. Mice were sacrificed at 3 days post-
inoculation (dpi) and the lungs were harvested in 1 mL of
PBS. The lung tissue was disrupted and then centrifuged.
Fifty microliters (50 μL) of supernatant was used to inocu-
late the subsequent naïve mouse in the series. The patho-
genicities of WT-DK619 and MA-DK619 were tested in 15
6-week-old female BALB/c mice inoculated intranasally
with 106.0 EID50 (50 μL). Three mice were sacrificed from
each group at 3, 6, and 9 dpi, and the viral titer in the lung,
brain, heart, liver, kidney, and spleen was determined in
embryonated chicken eggs by the Reed and Muench
method [17]. Survival and weight-loss were monitored in
the remaining six mice in each group until 14 dpi. A group
of mock-infected mice (n = 6) was included as a control.
All experiments with the H5N2 viruses were performed in
a Biosafety Level 3 laboratory.
Lung tissue samples from WT-6DK19 or MA-6DK19
infected mice were fixed in 10 % neutral buffered forma-
lin, embedded in paraffin, then cut into 4 μm-thick
sections and stained with hematoxylin and eosin (H&E).
Immunohistochemical staining was performed to detect
nucleoprotein antigens in the lungs. The tissues were in-
cubated overnight at 4 °C with a monoclonal antibody
against the influenza A virus nucleoprotein, then the
sections were washed 3 times with PBS and incubated
with an HRP–conjugated goat anti–mouse secondary
antibody. The sections were developed with 3–3′ diami-
nobenzidine and examined under a light microscope as
described previously [18].
To identify the virulence-associated molecular markers
of MA-6DK19, the whole genomes of MA-6DK19 and
WT-6DK19 were sequenced and compared to identify
amino acid changes. Viral RNA was extracted from the
supernatant of the disrupted lung tissue using TRIzol.
The Uni12 primer was used to synthesize cDNA from
viral RNA: 5ʹ-AGCAAAAGCAGG-3ʹ. RT-PCR was
conducted using a PrimeScript™ 1st Strand cDNA Synthe-
sis Kit and PrimeSTAR® Max DNA Polymerase (TaKaRa).
All of the gene segments from WT-6DK19 and MA-
6DK19 were amplified with segment-specific primers as
described previously [19]. All eight segments of these vi-
ruses sequenced using Sanger sequencing on an ABI 3730
genetic analyser (Applied Biosystems). The sequences
were analysed using BioEdit version 7.0.9.0 DNA software.
The sequence data of WT-6DK19 and MA-6DK19 have
been deposited in GenBank (accession nos. KJ933374-
KJ933381 and KX714303-KX714310).
Table 1 Nucleotide and amino acid substitutions identified in a mouse-adapted highly pathogenic H5N2 avian influenza virus
Segment Nucleotide position Nucleotide substitution Amino acid position Amino acid substitution




PB1 542 (T→ C) P7 T 181 (I→ T) I
P8 C T
P10 C T
2103 T→ C 701 -
2112 A→ G 704 -




NS 678 (A→ G) P8 A NS1, 226 (Terminator→W) Terminator
NS2, 69 (E→ G) E
P9 A/G NS1, 226 Terminator/(W, “WRNKVAD” was extended)
NS2, 69 E/G
P10 G NS1, 226 W, “WRNKVAD” was extended
NS2, 69 G
“-” Synonymous substitution
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Amino acid substitutions that increase the virulence of
H5 AIVs adapted to mammalian hosts have been shown
to emerge after the fifth or sixth passage through naïve
mice [20, 21]. Here, some of these mutations were detected
as early as the fourth passage (Table 1 and Additional file 1:
Figure S1). In contrast to mice infected with WT-MDK19
that exhibited minimal weight loss, mice infected with
MA-6DK19 exhibited rapid weight-loss beginning on 2
dpi (Fig. 1) and had clear clinical signs of illness. The sur-
vival rate for mice infected with WT-6DK19 was 83.3 %
(5/6) up to 14 dpi (Table 2). In contrast, none of mice in-
fected with MA-6DK19 survived to 14 dpi, indicating that
Fig. 1 Survival and body weight were measured in mice infected with the H5N2 viruses. Survival (a) and body weight (b) were measured in
BABL/c mice infected with the wild-type (WT-6DK19) or mouse-adapted (MA-6DK19) strains of an H5N2 avian influenza virus (n = 6/group). Each
mouse was infected intranasally with 106.0 EID50 of virus in a 50 μL volume. The number of surviving mice and their body weights were measured
daily from the date of challenge to 14 days post inoculation
Table 2 Viral titer of wild-type and mouse-adapted H5N2 avian influenza viruses in tissue
Virus Days
post-infection
Virus titers in organs of mice (log10 EID50/mL)
no. virus-positive mice/no. tested mice (mean titer ± SD)
Lung Spleen Kidney Liver Brain Heart
Wild-type virus
(WT-6DK19)
3 3/3(4.0 ± 0) 1/3(2.0 ± 0) 1/3(2.0 ± 0) 3/3(1.5 ± 0.5) 2/3(2.5 ± 0.5) 3/3(1.5 ± 0.5)
6 3/3(4.5 ± 0.5) 2/3(2.0 ± 0.0) 3/3(2.0 ± 0) 2/3(2.0 ± 0) 3/3(1.5 ± 0.5) 3/3(2.0 ± 0)
9 3/3(3.5 ± 0) 2/3(2.0 ± 0.0) 0/3 2/3(1.0 ± 0) 3/3(1.5 ± 0.5) 3/3(2.0 ± 0)
Mouse-adapted virus
(MA-6DK19)
3 3/3(5.5 ± 0.5) 3/3(2.5 ± 0.5) 3/3(3.0 ± 0) 3/3(2.5 ± 0.5) 3/3(2.5 ± 0.5) 3/3(3.0 ± 0)
6 ND ND ND ND ND ND
9 ND ND ND ND ND ND
Fifteen (15) mice/group were inoculated intranasally with 106.0 EID50 of either the wild-type (WT-6DK19) or mouse-adapted (MA-6DK19) viruses in a 50 μL volume.
Three mice per group were sacrificed at 3, 6, or 9 dpi and the lung, brain, heart, kidney, spleen, and liver tissues were collected. The viral titer in each tissue was
determined in embryonated chicken eggs by the Reed and Muench method. Values represent mean ± SD. ND: Not determined. None of mice infected with
MA-6DK19 survived past 5 dpi
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MA-6DK19 is more virulent in mice than WT-6DK19.
Mice infected with MA-6DK19 had multifocal severe
interstitial inflammatory hyperaemia and exudative patho-
logical changes, large lesions in the lung tissue, and red
blood cell and inflammatory cell infiltrates at 3 dpi (Fig. 2).
Cells infected with H5N2 AIV were detected in the bron-
chial epithelium and alveolar epithelium from infected
mice 3 dpi.
During the adaptation process, six nucleotide substitu-
tions and five amino acid substitutions were observed
(Table 1): (1) an E→K substitution in polymerase basic
protein 2 (PB2) at position 627, (2) an I→T substitution
in polymerase basic protein 1 (PB1) at position 181, (3)
an A→ S substitution in hemagglutinin (HA) at position
150, (4) seven amino acids (WRNKVAD) were added at
the C-terminal of the nonstructural protein 1 (NS1), and
(5) an E→G substitution in NS2 at position 69. The
E627K substitution in the PB2 protein has been reported
to influence host range and to confer increased virulence
in models of H3, H5, H6, and H9 infection [22–25]. The
A149 (or 150) substitution has been reported to be in-
volved in the 150-loop of the receptor binding domain
and is implicated in the adaptation of AIVs to mamma-
lian hosts [26, 27]. Previously, the C-terminal ESEV
motif has been shown to increase viral virulence when
introduced into the NS1 protein of mouse-adapted influ-
enza virus in a strain dependent manner [28, 29]. The
significance of the seven amino acid addition to MA-
6DK19 NS1 is not entirely clear [30], and it has been
observed frequently in H5N8 viruses in recent years
(Additional file 2: Table S1). Compared to WT-6DK19,
the mouse-adapted virus had expanded tissue tropism
and increased replication kinetics in vivo; however, the
substitutions that contributed to mouse adaptation re-
main to be further studied.
Mice are widely used to study the pathogenesis of
AIVs [25, 31]. Several amino acid substitutions in-
cluding PB2 (Q591K and D701N), polymerase acidic
protein (PA) (I554V), HA (S227N), and NP (R351K)
have been described in mouse adapted H5N2 AIVs
that have increased virulence and enhanced replica-
tion kinetics in mice and cell lines [20]. In this study,
amino acid substitutions, in the PB2 (E627K), PB1
(I181T), HA (A150S), NS1 (WRNKVAD was extended
at the C-terminal of the protein), and NS2 (E69G)
proteins were identified in a MA-6DK19. These
changes were associated with increased virulence
compared with the wild-type virus, and the mouse-
adapted virus became lethal in mice. These results
provide insights into the pathogenic potential of novel
reassortant H5N2 AIVs in mammals, and suggest that
continued H5N2 molecular epidemiology studies are
critical to understand the variability and evolutionary
mechanisms of AIVs.
Additional files
Additional file 1: Figure S1. Comparison of the PB2, PB1, HA, and NS
segment sequences of the H5N2 viruses in differnet passages. (DOC 316 kb)
Additional file 2: Table S1. Amino acid substitutions in PB2, PB1, HA,
NS1 and NS2 proteins of H5 influenza A viruses. (DOC 76 kb)
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AIVs: Avian influenza viruses; dpi: Days post-inoculation; EID50: 50 %
embryo infectious dose; HA: Hemagglutinin; LPMs: Live poultry markets;
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Fig. 2 Histology and immunohistochemistry of mice infected with
the mouse-adapted H5N2 avian influenza virus. Lung pathology was
determined in mice infected with mouse-adapted strain of an H5N2
avian influenza virus at 3 days post inoculation (dpi) (a). Hematoxylin
and eosin staining was used to examine the histology of the lung
tissue. Mice infected with the mouse-adapted virus displayed
severe interstitial pneumonia in lung tissues, shown by the alveolar
lumen flooded with dropout from alveolar cells, erythrocytes, and
inflammatory cells (diamond); and congestion in the blood vessels
(triangle). Viral nucleoprotein was detected in the lungs using
immunohistochemistry in mice infected with the mouse-adapted
viruses (b). Arrows indicate positively stained lung alveolar
epithelial cells
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